Authors

Sarab Shaher Almustafa

Assistant Lecturer, College of Nursing, University of Ninevah, Iraq

Asal Faiz Hameed Aldabbagh

Assistant Lecturer, College of Nursing, University of Ninevah, Iraq

Abstract

Aflatoxin-producing Aspergillus fungi produce hazardous compounds that often contaminate food in tropical regions. In some areas, the most harmful kind, aflatoxin B1 (AFB1), is a primary contributor to liver cancer, often known as hepatocellular carcinoma, or HCC. There is a significant frequency of aflatoxin contamination, and early onset of HCC has been linked to perinatal exposure to AFB1. The possible consequences of perinatal exposure to AFB1and possible epigenetic changes whichmightaffect the risk of cancer in the future are investigated in this study.

Two dosages of AFB1 (high: 5 mg/kg, low: 0.5 mg/kg) were administered to pregnant rats before conception, during pregnancy, and during the weaning process to investigate this. Next, these groups were contrasted with a control group that had not been exposed. The babies were kept under observation until they were three weeks or three months old, at which time samples of their liver and blood were taken for examination. Hormones related to reproduction, gonadotropin, and thyroid were assessed after three months, whereas body weights and lipid profiles were determined at three weeks and three months.

The children of high-dose prenatal AFB1 exposure had notable weight reductions: 16.3% at birth, 31.6% at three weeks, and 7.5% at three months, according to the results. The lipid and hormone profiles were likewise changed by both exposure levels. TP53gene and H19's DNA methylation levels in blood and liver samples were assessed using pyrosequencing. TP53 methylation was markedly elevated in blood samples from rats subjected to both low- and high-doses, but dramatically decreased in liver samples as compared to controls. In contrast, Rats exposed to the high-dose group had increased liver and decreased H19 methylation in their 3-month blood samples.

These findings thus point toward an increased risk of early-onset HCC, whether perinatal AFB1 exposure can lead to overt alterations in hormone, lipid, and weight profiles with modulation of epigenetic regulation. Further studies are needed to completely understand the long-term implications of these modifications leading to cancer development.

Keywords

Gestational exposure AFB1 hormones lipid liver DNA methylation developmental causes

Citation of this Article

Sarab Shaher Almustafa, & Asal Faiz Hameed Aldabbagh. (2025). Assessment of Rats Exposed to Aflatoxin B1 Early in Life and Impact on the Offspring. Journal of Artificial Intelligence and Emerging Technologies (JAIET). 2(8), 6-16. Article DOI: https://doi.org/10.47001/JAIET/2025.208002

Licence Copyright (c) 2026 Journal of Artificial Intelligence and Emerging Technologies. This work is licensed under a Creative Commons Attribution Non Commercial 4.0 International Licence.

References

  1. Gluckman P.D., Hanson M.A., Cooper C., Thornburg K.L. Effect of in utero and early-life conditions on adult health and disease. N. Engl. J. Med. 2008; 359:61–73. doi: 10.1056/NEJMra0708473.
  2. Barker D.J., Osmond C., Forsen T.J., Kajantie E., Eriksson J.G. Trajectories of growth among children who have coronary events as adults. N. Engl. J. Med. 2005;353:1802–1809. doi: 10.1056/NEJMoa044160.
  3. Walker C.L., Ho S.-M. Developmental reprogramming of cancer susceptibility. Nat. Rev. Cancer. 2012;12:479–486. doi: 10.1038/nrc3220.
  4. Sharma S., Kohli C., Johnson L., Bennet L., Brusselaers N., Nilsson P.M. Birth size and cancer prognosis: A systematic review and meta-analysis. J. Dev. Orig. Health Dis. 2020; 11:309–316. doi: 10.1017/S2040174419000631.
  5. Spector L.G., Puumala S.E., Carozza S.E., Chow E.J., Fox E.E., Horel S., Johnson K.J., McLaughlin C.C., Reynolds P., Von Behren J. Cancer risk among children with very low birth weights. Pediatrics. 2009;124:96–104. doi: 10.1542/peds.2008-3069.
  6. Ikeda H., Matsuyama S., Tanimura M. Association between hepatoblastoma and very low birth weight: A trend or a chance? J. Pediatr. 1997;130:557–560. doi: 10.1016/S0022-3476(97)70239-7.
  7. Zimmermann E., Berentzen T.L., Gamborg M., Sørensen T.I., Baker J.L. Sex-specific associations between birth weight and adult primary liver cancer in a large cohort of D anish children. Int. J. Cancer. 2016;138:1410–1415. doi: 10.1002/ijc.29900.
  8. Sandboge S., Perälä M.-M., Salonen M.K., Blomstedt P.A., Osmond C., Kajantie E., Barker D.J., Eriksson J.G. Early growth and non-alcoholic fatty liver disease in adulthood—the NAFLD liver fat score and equation applied on the Helsinki Birth Cohort Study. Ann. Med. 2013;45:430–437. doi: 10.3109/07853890.2013.801275.
  9. Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat. Rev. Genet. 2002; 3:662–673. doi: 10.1038/nrg887.
  10. Reik W., Dean W., Walter J. Epigenetic reprogramming in mammalian development. Science. 2001;293:1089–1093. doi: 10.1126/science.1063443.
  11. Silva Lima B., Van der Laan J.W. Mechanisms of Nongenotoxic Carcinogenesis and Assessment of the Human Hazard. Regul. Toxicol. Pharm. 2000;32:135–143. doi: 10.1006/rtph.2000.1427.
  12. St-Pierre J., Hivert M.F., Perron P., Poirier P., Guay S.P., Brisson D., Bouchard L. IGF2 DNA methylation is a modulator of newborn’s fetal growth and development. Epigenet. Off. J. DNA Methylation Soc. 2012; 7:1125–1132. doi: 10.4161/epi.21855.
  13. Amarger V., Giudicelli F., Pagniez A., Parnet P. Perinatal high methyl donor alters gene expression in IGF system in male offspring without altering DNA methylation. Future Sci. OA. 2017;3:Fso164. doi: 10.4155/fsoa-2016-0077.
  14. Agrogiannis G.D., Sifakis S., Patsouris E.S., Konstantinidou A.E. Insulin-like growth factors in embryonic and fetal growth and skeletal development (Review) Mol. Med. Rep. 2014;10:579–584. doi: 10.3892/mmr.2014.2258.
  15. Jones P.A. Functions of DNA methylation: Islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 2012;13:484–492. doi: 10.1038/nrg3230.
  16. Dolinoy D.C., Huang D. Jirtle, R.L. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc. Natl. Acad. Sci. USA. 2007;104:13056–13061. doi: 10.1073/pnas.0703739104.
  17. Montrose L., Padmanabhan V., Goodrich J.M., Domino S.E., Treadwell M.C., Meeker J.D., Watkins D.J., Dolinoy D.C. Maternal levels of endocrine disrupting chemicals in the first trimester of pregnancy are associated with infant cord blood DNA methylation. Epigenetics. 2018;13:301–309. doi: 10.1080/15592294.2018.1448680.
  18. Neier K., Cheatham D., Bedrosian L.D., Dolinoy D.C. Perinatal exposures to phthalates and phthalate mixtures result in sex-specific effects on body weight, organ weights and intracisternal A-particle (IAP) DNA methylation in weanling mice. J. Dev. Orig. Health Dis. 2019;10:176–187. doi: 10.1017/S2040174418000430.
  19. Hernandez-Vargas H., Castelino J., Silver M.J., Dominguez-Salas P., Cros M.P., Durand G., Le Calvez-Kelm F., Prentice A.M., Wild C.P., Moore S.E., et al. Exposure to aflatoxin B1 in utero is associated with DNA methylation in white blood cells of infants in The Gambia. Int. J. Epidemiol. 2015;44:1238–1248. doi: 10.1093/ije/dyv027.
  20. Zhang Y.J., Rossner P., Jr., Chen Y., Agrawal M., Wang Q., Wang L., Ahsan H., Yu M.W., Lee P.H., Santella R.M. Aflatoxin B1 and polycyclic aromatic hydrocarbon adducts, p53 mutations and p16 methylation in liver tissue and plasma of hepatocellular carcinoma patients. Int. J. Cancer. 2006; 119:985–991. doi: 10.1002/ijc.21699.
  21. Zhang Y.J., Wu H.C., Yazici H., Yu M.W., Lee P.H., Santella R.M. Global hypomethylation in hepatocellular carcinoma and its relationship to aflatoxin B(1) exposure. World J. Hepatol. 2012;4:169–175. doi: 10.4254/wjh.v4.i5.169.
  22. Livingstone M.C., Johnson N.M., Roebuck B.D., Kensler T.W., Groopman J.D. Profound changes in miRNA expression during cancer initiation by aflatoxin B(1) and their abrogation by the chemopreventive triterpenoid CDDO-Im. Mol. Carcinog. 2017; 56:2382–2390. doi: 10.1002/mc.22635.
  23. Wu H.C., Wang Q., Yang H.I., Tsai W.Y., Chen C.J., Santella R.M. Global DNA methylation in a population with aflatoxin B1 exposure. Epigenetics. 2013;8:962–969. doi: 10.4161/epi.25696.
  24. Kumi J., Mitchell N., Asare G., Dotse E., Kwaa F., Phillips T., Ankrah N. Aflatoxins and fumonisins contamination of home-made food (weanimix) from cereal-legume blends for children. Ghana Med. J. 2014;48:121–126. doi: 10.4314/gmj.v48i3.1.
  25. Benkerroum N. Aflatoxins: Producing-Molds, Structure, Health Issues and Incidence in Southeast Asian and Sub-Saharan African Countries. Int. J. Environ. Res. Public Health. 2020;17:1215. doi: 10.3390/ijerph17041215.
  26. Xue K.S., Tang L., Shen C.L., Pollock B.H., Guerra F., Phillips T.D., Wang J.-S. Increase in aflatoxin exposure in two populations residing in East and West Texas, United States. Int. J. Hyg. Environ. Health. 2020;231:113662. doi: 10.1016/j.ijheh.2020.113662.
  27. Nazhand A., Durazzo A., Lucarini M., Souto E.B., Santini A. Characteristics, Occurrence, Detection and Detoxification of Aflatoxins in Foods and Feeds. Foods. 2020;9:644. doi: 10.3390/foods9050644.
  28. Gruber-Dorninger C., Jenkins T., Schatzmayr G. Global mycotoxin occurrence in feed: A ten-year survey. Toxins. 2019;11:375. doi: 10.3390/toxins11070375.
  29. Zhang N.-Y., Qi M., Gao X., Zhao L., Liu J., Gu C.-Q., Song W.-J., Krumm C.S., Sun L.-H., Qi D.-S. Response of the hepatic transcriptome to aflatoxin B 1 in ducklings. Toxicon. 2016;111:69–76. doi: 10.1016/j.toxicon.2015.12.022.
  30. Deng J., Zhao L., Zhang N.-Y., Karrow N.A., Krumm C.S., Qi D.-S., Sun L.-H. Aflatoxin B1 metabolism: Regulation by phase I and II metabolizing enzymes and chemoprotective agents. Mutat. Res. Rev. Mutat. Res. 2018;778:79–89. doi: 10.1016/j.mrrev.2018.10.002.
  31. Benkerroum N. Chronic and acute toxicities of aflatoxins: Mechanisms of action. Int. J. Environ. Res. Public Health. 2020;17:423. doi: 10.3390/ijerph17020423.
  32. Ferlay J., Soerjomataram I., Dikshit R., Eser S., Mathers C., Rebelo M., Parkin D.M., Forman D., Bray F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer. 2015;136:E359–E386. doi: 10.1002/ijc.29210.
  33. Rieswijk L., Claessen S.M., Bekers O., van Herwijnen M., Theunissen D.H., Jennen D.G., de Kok T.M., Kleinjans J.C., van Breda S.G. Aflatoxin B1 induces persistent epigenomic effects in primary human hepatocytes associated with hepatocellular carcinoma. Toxicology. 2016;350:31–39. doi: 10.1016/j.tox.2016.05.002.
  34. Khlangwiset P., Shephard G.S., Wu F. Aflatoxins and growth impairment: A review. Crit. Rev. Toxicol. 2011;41:740–755. doi: 10.3109/10408444.2011.575766.
  35. Fujitake S., Hibi K., Okochi O., Kodera Y., Ito K., Akiyama S., Nakao A. Aberrant methylation of SOCS-1 was observed in younger colorectal cancer patients. J. Gastroenterol. 2004;39:120–124. doi: 10.1007/s00535-003-1262-0.
  36. Steele R., Lane D. P53 in cancer: A paradigm for modern management of cancer. Surgeon. 2005;3:197–205. doi: 10.1016/S1479-666X(05)80041-1.
  37. Rotimi O.A., Rotimi S.O., Oluwafemi F., Ademuyiwa O., Balogun E.A. Coexistence of aflatoxicosis with protein malnutrition worsens hepatic oxidative damage in rats. J. Biochem. Mol. Toxicol. 2016;30:269–276. doi: 10.1002/jbt.21787.
  38. Charni-Natan M., Aloni-Grinstein R., Osher E., Rotter V. Liver and Steroid Hormones—Can a Touch of p53 Make a Difference? Front. Endocrinol. 2019;10:374. doi: 10.3389/fendo.2019.00374.
  39. Goldstein I., Ezra O., Rivlin N., Molchadsky A., Madar S., Goldfinger N., Rotter V. p53, a novel regulator of lipid metabolism pathways. J. Hepatol. 2012;56:656–662. doi: 10.1016/j.jhep.2011.08.022.
  40. Lacroix M., Riscal R., Arena G., Linares L.K., Le Cam L. Metabolic functions of the tumor suppressor p53: Implications in normal physiology, metabolic disorders, and cancer. Mol. Metab. 2020;33:2–22. doi: 10.1016/j.molmet.2019.10.002.
  41. Berger C., Qian Y., Chen X. The p53-estrogen receptor loop in cancer. Curr. Mol. Med. 2013;13:1229–1240. doi: 10.2174/15665240113139990065.
  42. Dinda S., Sanchez A., Moudgil V. Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells. Oncogene. 2002;21:761–768. doi: 10.1038/sj.onc.1205136.
  43. Rotimi O.A., Rotimi S.O., Duru C.U., Ebebeinwe O.J., Abiodun A.O., Oyeniyi B.O., Faduyile F.A. Acute aflatoxin B1–Induced hepatotoxicity alters gene expression and disrupts lipid and lipoprotein metabolism in rats. Toxicol. Rep. 2017;4:408–414. doi: 10.1016/j.toxrep.2017.07.006.
  44. Rotimi O.A., Rotimi S.O., Goodrich J.M., Adelani I.B., Agbonihale E., Talabi G. Time-course effects of acute aflatoxin B1 exposure on hepatic mitochondrial lipids and oxidative stress in rats. Front. Pharmacol. 2019;10:467. doi: 10.3389/fphar.2019.00467.
  45. Ugbaja R.N., Okedairo O.M., Oloyede A.R., Ugwor E.I., Akinloye D.I., Ojo O.P., Ademuyiwa O. Probiotics consortium synergistically ameliorates aflatoxin B1-induced disruptions in lipid metabolism of female albino rats. Toxicon. 2020;186:109–119. doi: 10.1016/j.toxicon.2020.08.007.
  46. Supriya C., Girish B., Reddy P.S. Aflatoxin B1-induced reproductive toxicity in male rats: Possible mechanism of action. Int. J. Toxicol. 2014;33:155–161. doi: 10.1177/1091581814530764.
  47. Adedara I.A., Nanjappa M.K., Farombi E.O., Akingbemi B.T. Aflatoxin B1 disrupts the androgen biosynthetic pathway in rat Leydig cells. Food Chem. Toxicol. 2014;65:252–259. doi: 10.1016/j.fct.2013.12.027.
  48. Chen X., Li C., Chen Y., Ni C., Chen X., Zhang L., Xu X., Chen M., Ma X., Zhan H. Aflatoxin B1 impairs leydig cells through inhibiting AMPK/mTOR-mediated autophagy flux pathway. Chemosphere. 2019;233:261–272. doi: 10.1016/j.chemosphere.2019.05.273.
  49. Cui H., Cruz-Correa M., Giardiello F.M., Hutcheon D.F., Kafonek D.R., Brandenburg S., Wu Y., He X., Powe N.R., Feinberg A.P. Loss of IGF2 imprinting: A potential marker of colorectal cancer risk. Science. 2003;299:1753–1755. doi: 10.1126/science.1080902.
  50. Yoshimura H., Matsuda Y., Yamamoto M., Kamiya S., Ishiwata T. Expression and role of long non-coding RNA H19 in carcinogenesis. Front. Biosci. 2018;23:614–625. doi: 10.2741/4608.
  51. Raveh E., Matouk I.J., Gilon M., Hochberg A. The H19 Long non-coding RNA in cancer initiation, progression and metastasis—A proposed unifying theory. Mol. Cancer. 2015;14:184. doi: 10.1186/s12943-015-0458-2.
  52. Adetunji M., Atanda O., Ezekiel C.N., Sulyok M., Warth B., Beltrán E., Krska R., Obadina O., Bakare A., Chilaka C.A. Fungal and bacterial metabolites of stored maize (Zea mays, L.) from five agro-ecological zones. Mycotoxin Res. 2014;30:89–102. doi: 10.1007/s12550-014-0194-2.
  53. Grunau C., Clark S.J., Rosenthal A. Bisulfite genomic sequencing: Systematic investigation of critical experimental parameters. Nucleic Acids Res. 2001;29:E65. doi: 10.1093/nar/29.13.e65.
  54. Tost J., Gut I.G. Analysis of gene-specific DNA methylation patterns by pyrosequencing technology. Methods Mol. Biol. 2007;373:89–102. doi: 10.1385/1-59745-377-3:89.
  55. He X., Xie Z., Dong Q., Li J., Li W., Chen P. Effect of Folic Acid Supplementation on Renal Phenotype and Epigenotype in Early Weanling Intrauterine Growth Retarded Rats. Kidney Blood Press Res. 2015;40:395–402. doi: 10.1159/000368516.
  56. Goodrich J.M., Sanchez B.N., Dolinoy D.C., Zhang Z., Hernandez-Avila M., Hu H., Peterson K.E., Tellez-Rojo M.M. Quality Control and Statistical Modeling for Environmental Epigenetics: A Study on in Utero Lead Exposure and DNA Methylation at Birth. Epigenetics. 2015;10:19–30. doi: 10.4161/15592294.2014.989077.
  57. Kihara T., Matsuo T., Sakamoto M., Yasuda Y., Yamamoto Y., Tanimura T. Effects of prenatal aflatoxin B1 exposure on behaviors of rat offspring. Toxicol. Sci. 2000;53:392–399. doi: 10.1093/toxsci/53.2.392.
  58. Supriya C., Akhila B., Pratap Reddy K., Girish B., Sreenivasula Reddy P. Effects of maternal exposure to aflatoxin B1 during pregnancy on fertility output of dams and developmental, behavioral and reproductive consequences in female offspring using a rat model. Toxicol. Mech. Methods. 2016;26:202–210. doi: 10.3109/15376516.2016.1151967.
  59. Supriya C., Reddy P.S. Prenatal exposure to aflatoxin B1: Developmental, behavioral, and reproductive alterations in male rats. Sci. Nat. 2015;102:26. doi: 10.1007/s00114-015-1274-7.
  60. Turner P.C., Collinson A.C., Cheung Y.B., Gong Y., Hall A.J., Prentice A.M., Wild C.P. Aflatoxin exposure in utero causes growth faltering in Gambian infants. Int. J. Epidemiol. 2007;36:1119–1125. doi: 10.1093/ije/dym122.
  61. Lee B.J., Kim J.Y. Identification of metabolic syndrome using phenotypes consisting of triglyceride levels with anthropometric indices in Korean adults. BMC Endocr. Disord. 2020;20:1–12. doi: 10.1186/s12902-020-0510-0.
  62. Chatterjee C., Sparks D.L. Hepatic lipase, high density lipoproteins, and hypertriglyceridemia. Am. J. Pathol. 2011;178:1429–1433. doi: 10.1016/j.ajpath.2010.12.050.
  63. Liu J., Zeng F.F., Liu Z.M., Zhang C.X., Ling W.H., Chen Y.M. Effects of blood triglycerides on cardiovascular and all-cause mortality: A systematic review and meta-analysis of 61 prospective studies. Lipids Health Dis. 2013;12:159. doi: 10.1186/1476-511X-12-159.
  64. Abdel-Wahhab M.A., El-Nekeety A.A., Hathout A.S., Salman A.S., Abdel-Aziem S.H., Sabry B.A., Hassan N.S., Abdel-Aziz M.S., Aly S.E., Jaswir I. Bioactive compounds from Aspergillus niger extract enhance the antioxidant activity and prevent the genotoxicity in aflatoxin B1-treated rats. Toxicon. 2020;181:57–68. doi: 10.1016/j.toxicon.2020.04.103.
  65. El-Nekeety A.A., Abdel-Azeim S.H., Hassan A.M., Hassan N.S., Aly S.E., Abdel-Wahhab M.A. Quercetin inhibits the cytotoxicity and oxidative stress in liver of rats fed aflatoxin-contaminated diet. Toxicol. Rep. 2014;1:319–329. doi: 10.1016/j.toxrep.2014.05.014.
  66. Hu J., Zhang Z., Shen W.-J., Azhar S. Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones. Nutr. Metab. 2010;7:47. doi: 10.1186/1743-7075-7-47.
  67. Giatti S., Diviccaro S., Serafini M.M., Caruso D., Garcia-Segura L.M., Viviani B., Melcangi R.C. Sex differences in steroid levels and steroidogenesis in the nervous system: Physiopathological role. Front. Neuroendocrinol. 2020;56:100804. doi: 10.1016/j.yfrne.2019.100804.
  68. Trejter M., Hochol A., Tyczewska M., Ziolkowska A., Jopek K., Szyszka M., Malendowicz L.K., Rucinski M. Sex-related gene expression profiles in the adrenal cortex in the mature rat: Microarray analysis with emphasis on genes involved in steroidogenesis. Int. J. Mol. Med. 2015;35:702–714. doi: 10.3892/ijmm.2015.2064.
  69. Hasanzadeh S., Hosseini E., Rezazadeh L. Effects of Aflatoxin B1 on Profiles of Gonadotropic (FSH and LH), Steroid (Testosterone and 17β-Estradiol) and Prolactin Hormones in Adult Male Rat. Iran. J. Vet. Res. 2011;12:332–336.
  70. Abu El-Saad A.S., Mahmoud H.M. Phytic acid exposure alters aflatoxinB1-induced reproductive and oxidative toxicity in albino rats (Rattus norvegicus) Evid. Based Complement. Altern. Med. 2009;6:107398. doi: 10.1093/ecam/nem137.
  71. Amin Y., Mohamed R., Zakaria A., Wehrend A., Hussein H.A. Effects of aflatoxins on some reproductive hormones and composition of buffalo’s milk. Comp. Clin. Pathol. 2019;28:1191–1196. doi: 10.1007/s00580-019-03006-w.
  72. Onuzulu C.D., Rotimi O.A., Rotimi S.O. Epigenetic modifications associated with in utero exposure to endocrine disrupting chemicals BPA, DDT and Pb. Rev. Environ. Health. 2019;34:309–325. doi: 10.1515/reveh-2018-0059.
  73. Flavahan W.A., Gaskell E., Bernstein B.E. Epigenetic plasticity and the hallmarks of cancer. Science. 2017;357:eaal2380. doi: 10.1126/science.aal2380.
  74. Darwiche N. Epigenetic mechanisms and the hallmarks of cancer: An intimate affair. Am. J. Cancer Res. 2020;10:1954–1978.
  75. Wang S., He Z., Li D., Zhang B., Li M., Li W., Zhu W., Xing X., Zeng X., Wang Q., et al. Aberrant methylation of RUNX3 is present in Aflatoxin B(1)-induced transformation of the L02R cell line. Toxicology. 2017;385:1–9. doi: 10.1016/j.tox.2017.04.011.
  76. Marrone A.K., Tryndyak V., Beland F.A., Pogribny I.P. MicroRNA Responses to the Genotoxic Carcinogens Aflatoxin B1 and Benzo[a]pyrene in Human HepaRG Cells. Toxicol. Sci. 2016;149:496–502. doi: 10.1093/toxsci/kfv253.
  77. Tryndyak V., Kindrat I., Dreval K., Churchwell M.I., Beland F.A., Pogribny I.P. Effect of aflatoxin B(1), benzo[a]pyrene, and methapyrilene on transcriptomic and epigenetic alterations in human liver HepaRG cells. Food Chem. Toxicol. 2018;121:214–223. doi: 10.1016/j.fct.2018.08.034.
  78. Zhang Y.J., Chen Y., Ahsan H., Lunn R.M., Chen S.Y., Lee P.H., Chen C.J., Santella R.M. Silencing of glutathione S-transferase P1 by promoter hypermethylation and its relationship to environmental chemical carcinogens in hepatocellular carcinoma. Cancer Lett. 2005;221:135–143. doi: 10.1016/j.canlet.2004.08.028.
  79. Zhang Y.J., Ahsan H., Chen Y., Lunn R.M., Wang L.Y., Chen S.Y., Lee P.H., Chen C.J., Santella R.M. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Mol. Carcinog. 2002;35:85–92. doi: 10.1002/mc.10076.
  80. Hussain S.P., Schwank J., Staib F., Wang X.W., Harris C.C. TP53 mutations and hepatocellular carcinoma: Insights into the etiology and pathogenesis of liver cancer. Oncogene. 2007;26:2166–2176. doi: 10.1038/sj.onc.1210279.
  81. Menendez D., Inga A., Resnick M.A. The biological impact of the human master regulator p53 can be altered by mutations that change the spectrum and expression of its target genes. Mol. Cell. Biol. 2006;26:2297–2308. doi: 10.1128/MCB.26.6.2297-2308.2006.
  82. Hoyo C., Daltveit A.K., Iversen E., Benjamin-Neelon S.E., Fuemmeler B., Schildkraut J., Murtha A.P., Overcash F., Vidal A.C., Wang F., et al. Erythrocyte folate concentrations, CpG methylation at genomically imprinted domains, and birth weight in a multiethnic newborn cohort. Epigenetics. 2014;9:1120–1130. doi: 10.4161/epi.29332.
  83. LaRocca J., Binder A.M., McElrath T.F., Michels K.B. The impact of first trimester phthalate and phenol exposure on IGF2/H19 genomic imprinting and birth outcomes. Environ. Res. 2014;133:396–406. doi: 10.1016/j.envres.2014.04.032.
  84. Lee H.S., Barraza-Villarreal A., Biessy C., Duarte-Salles T., Sly P.D., Ramakrishnan U., Rivera J., Herceg Z., Romieu I. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. Physiol. Genom. 2014;46:851–857. doi: 10.1152/physiolgenomics.00061.2014.
  85. Soubry A., Murphy S., Huang Z., Murtha A., Schildkraut J., Jirtle R., Wang F., Kurtzberg J., Demark-Wahnefried W., Forman M., et al. The effects of depression and use of antidepressive medicines during pregnancy on the methylation status of the IGF2 imprinted control regions in the offspring. Clin. Epigenet. 2011;3:2. doi: 10.1186/1868-7083-3-2.
  86. Yang M.-L., Huang Z., Wang Q., Chen H.-H., Ma S.-N., Wu R., Cai W.-S. The association of polymorphisms in lncRNA-H19 with hepatocellular cancer risk and prognosis. Biosci. Rep. 2018;38:BSR20171652. doi: 10.1042/BSR20171652.